In the juxtamedullary region, efferent arterioles branch after leaving the glomeruli. Some of these branches contribute to the peritubular capillary networks surrounding loops of Henle and collecting ducts in the outer medulla; other branches form bundles of vessels, the vasa recta, which make no contact with proximal tubular tissue, as is the case elsewhere in the renal cortex, but penetrate deep into the medulla before further branching.
Renal Tubular Anatomy
The glomerular filtrate flows from the glomerular capsule (Bowman's capsule) into the proximal tubule, which consists of a convoluted (pars convoluta) and a straight segment (pars recta). Detailed examination of proximal tubular cell types actually reveals three segments rather than two: SI, the proximal portion of the pars convoluta, S2, the distal pars convoluta and proximal pars recta, and S3, the distal pars recta.
Anaesthesia and Intensive Care. Vol. 1/, No. 4 . From the pars recta, tubular fluid enters the loop of Henle, consisting of an initial thin segment, which conducts urine towards or into the medulla, followed by a thick ascending segment. At the end of this thick ascending portion, the distal tubule begins, and comes into contact with the glomerulus from which it originated, and with the afferent and efferent arterioles connected to that glomerulus. These three structures at this point form the juxtaglomerular apparatus which is responsible for the regulation of renal blood flow, and is to some extent involved in the control of systemic arterial blood pressure ( Figure 2 ). The juxtaglomerular apparatus is characterised by a number of specialised cells. The distal tubular epithelium in this region shows large columnar cells, which make up the macula densa. These cells are in intimate contact with granular cells lining the afferent and efferent arterioles, and also with a group of cells known as the lacis or polkissen (polar cushion), which occupy the space between the three structures ( Figure 3 and vide infra Figure  12 ). The distal convoluted tubule is functionally and structurally an area of transition between the loop of Henle and the collecting duct, which runs directly from the cortex through the medulla, opening at a papilla into the renal pelvis.
ARTERIOLES --t-n----t--trr''«!b:.-''=-<:-+-MACULA DENSA AREA PROXIMAL TUBULE ---+---+-I--GLOMERULUS The juxtamedullary nephrons have a number of special features. These include larger glomeruli, long proximal tubules and long loops of Henle which extend deep into the renal medulla. The renal medulla therefore consists of the collecting ducts, the long loops of Henle derived from the juxtamedullary nephrons, and the parallel long vascular loops of the vasa recta, and these latter two structures produce a uniquely hypertonic extracellular fluid which has a major influence on the composition of urine flowing through the collecting ducts ( Figure 2 ).
ApPLIED PHYSIOLOGY OF THE KIDNEY
Introduction
Although the kidneys receive 25070 of the cardiac output, they represent only 0.4% of total body mass. Yet they are the prime organs in maintaining the homeostasis of the milieu interieur. In the adult, close to 180 litres of glomerular filtrate pass into the proximal nephron each day, equivalent to 60 times the plasma volume. However, glomerular filtration rate (GFR) varies greatly during any 24-hour period (range: 10-200, mean 125 mllmin in average-sized adults). Over 99% of the glomerular filtrate is reabsorbed together with other essential substances, either passively or by energy-requiring processes. It is not surprising that the kidney has the highest oxygen consumption per gram of tissue of any major body organ (6 mll 1 00 gm/min). The reabsorption of sodium accounts for over half of the oxygen consumption. In contrast to other tissues, oxygen consumption varies with blood flow and the arteriovenous oxygen content difference of 1-2 mll100 ml does not change with alterations in blood flow. Thus, the magnitude of blood flow determines the filtration rate, amount of sodium presented for reabsorption, work to be done and consequent oxygen consumption.
Renal Blood Flow and Glomerular
Filtration The sites of greatest vascular resistance in the renal vascular tree, and therefore the most important control areas, are the glomerular afferent and efferent arterioles. Under normal circumstances, glomerular blood flow is controlled so that about 20% of the glomerular plasma flow is filtered into the tubules. The major force favouring filtration in the glomerulus is the capillary hydrostatic pressure (Pgc), which depends on the cardiac output, the systemic arterial blood pressure, and the state of contraction or relaxation of the afferent and efferent arterioles ( Figure 4 ). This is opposed by the colloid osmotic pressure (TTb) of the blood, and the capsular or tubular hydrostatic pressure (Pt). Thus, the net filtration pressure (Pr) can be expressed asPr=Pgc-Pt-rrb The filtration pressure falls along the length of the glomerular capillary as the plasma colloid osmotic pressure rises, due to filtration of protein-free fluid from the capillary. This rise in colloid osmotic pressure becomes less as glomerular blood flow increases, and therefore the net filtration pressure increases with increasing renal blood flow. As blood flows through the remainder of the renal vasculature, hydrostatic pressure gradually falls as colloid osmotic pressure rises. This favours reabsorption of fluid into the bloodstream, from the peritubular capillary bed onwards ( Figure 5 ). The glomerular filtration rate depends not only on the filtration pressure but on the glomerular capillary permeability, which is 10 to 100 times that of capillaries elsewhere, and the total glomerular capillary surface area. Either or both of these may be reduced in disease states. The product of the latter two variables is the filtration coefficient (Kf). 
The Juxtaglomerular Apparatus
The resistance provided by the afferent and efferent arterioles is low compared with that offered by the arterioles of other organs, and as a consequence, in health, there is always some blood flow in all the renal capillaries, rather than the intermittent opening and closing of individual capillaries which occurs elsewhere in the body (vasomotion). Sympathetic vasoconstrictor fibres arising from T4-Lj spinal segments, passing via the coeliac plexus, innervate both arterioles and the smooth muscle of the initial portions of the vasa recta.
Parasympathetic fibres also innervate the arterioles, and probably pass via the renal hilum. Their function is unknown.
Both alpha and beta adrenergic receptors are present in the arterioles, but alpha receptors greatly outnumber beta, and both adrenaline and noradrenaline at all dose levels produce vasoconstriction. The mechanism by which low-dose adrenaline increases urine flow and osmolality in septic shock is currently not known.
Dopamine is present in high concentrations
in the renal cortex and there appear to be specific receptors for it. Its physiological role is not known, but pharmacologically, small doses of dopamine cause vasodilation, mediated by specific receptors, while larger doses produce vasoconstriction, mediated by alpha adrenergic receptors.
The release of renin by the kidney results ultimately in the formation of angiotensin II, which is returned to the kidney by the circulation and can cause vasoconstriction. A detailed review of the renin-angiotensin system may be found elsewhere in this symposium. (See also Figure 12. ) Prostaglandin E2 is a vasodilator, and is produced in the renal medulla from where it may be carried by tubular fluid to the juxtaglomerular apparatus. There is evidence of a close relationship between prostaglandin E2 and the renin-angiotensin system.
Renal Autoregulation
In the absence of extrinsic neural and hormonal influences, renal blood flow (RBF) and glomerular filtration rate (GFR) are maintained relatively constant over a range of mean arterial pressure of approximately 80-180 mmHg ( Figure 6 ). It is clear that this effect is mediated by changing arteriolar tone, especially in the afferent arteriole, but the mechanism by which this occurs remains poorly understood. Elegant micropipette techniques suggest that each nephron is somehow able to control the GFR of its own glomerulus, and this is termed "tubulo-glomerular feedback". The macula densa is believed to be central to this phenomenon, but neither the signal detected by the macula densa nor the mechanism by which it responds is known. Several extrarenal factors superimpose major influences upon this autoregulatory mechanism. The central blood volume modulates both RBF and, under physiological circumstances, GFR, possibly via atrial stretch receptors. In sodium depletion, hypovolaemia and low cardiac output states, renin release and angiotensin synthesis are stimulated, leading to a reduction in RBF and, to a lesser extent, GFR. However, evidence for a major role of angiotensin in the regulation of RBF and GFR under physiological conditions is not strong. Increased circulating levels of adrenaline also reduce RBF to a greater degree than GFR. Prostaglandin E2 production by the kidney is increased under circumstances of renal vasoconstriction, and may modulate the vasoconstrictive effect.
Intra-Renal Blood Flow Distribution
Ninety per cent of the renal blood flow is received by the highly vascular cortex. The factors which control intra-renal blood flow distribution are not known. However, it has been suggested that sustained reduction in renal cortical perfusion, to a level where glomerular filtration ceases, may be a critical factor in the pathogenesis of acute renal failure (ARF). In some patients with renal failure, Hollenberg et al. 5 reported that the rapid flow compartment, as determined by a 85Kr washout/renal arteriography technique, was markedly reduced. This was thought to represent cortical blood flow, and seemed to be markedly reduced or absent in patients with acute renal failure secondary to hypotension or nephrotoxins but was only reduced in proportion to total RBF in patients with chronic renal failure. The results of experimentation in this area remain contradictory, and neither the significance nor mechanism of such changes is understood. TuBULAR 
FUNCTION
Broadly there are four major methods by which the tubules handle endogenous and exogenous substances; all are based on the three basic functions of the nephron, filtration, reabsorption and secretion ( Figure 7 ).
Tubular Transport Mechanisms
Passive diffusion is the simplest type of tubular transport. Net movement of solutes occurs in the direction of concentration, osmotic, or electrical gradients, which are created by various transport mechanisms. In the case of weak acids and bases, gradients are established by alterations in tubular pH. As a weak base moves from the slightly alkaline blood to an acid tubular fluid, it tends to become the ionised, lipid-insoluble form, which is relatively non-diffusible, and tends to remain trapped in the urine (diffusion trapping). The non-ionised form therefore tends to continue to move down its concentration gradient from blood to urine. Procaine is an example of a solute whose excretion may be affected in this way. The converse is illustrated by phenobarbitone, a weak acid, largely present in unionised form in blood, whose excretion is slowed by the presence of an acid urine, and favoured by an alkaline urine.
Some solutes pass through membranes more rapidly than could be explained by passive diffusion alone, and in some of these cases it is thought that temporary bonding to a carrier substance in the cell membrane results in facilitated diffusion. Still other solutes are transported by carriers against electrochemical gradients, by processes requiring energy expenditure, and this is termed active transport.
Both these carrier-mediated types of transport demonstrate the properties of specificity, competition and saturation.
Some of these mechanisms are capacitylimited, i.e. they have a relatively fixed rate of transport regardless of the concentration gradient (glucose transport is an example). Other mechanisms are gradient-limited (e.g. sodium transport in the distal tubule). A transport mechanism tends to be gradientlimited when the tubular epithelium is relatively permeable to that substance, i.e. when there is a strong tendency for back diffusion. In the case of sodium transport, this tendency is limited by passive reabsorption of water accompanying reabsorbed sodium, which keeps tubular and plasma sodium concentrations roughly equal. Gradient-limited mechanisms are also affected by the flow rate of tubular fluid, i.e. their performance is improved when tubular flow is high.
In some cases, an active transport mechanism may drive the movement of a second solute. For instance, in the proximal tubule, active reabsorption of sodium facilitates the reabsorption of glucose. Such mechanisms are referred to as "co-transport" systems. When movement of the second solute occurs in the same direction as the first, this is known as a symport system; when a co-transport system is used to exchange substances across a membrane, as in the case of the Na-K pump, this is referred to as antiport system.
Solute handling in the proximal tubule
Urea is freely filtered at the glomerulus, but is also passively reabsorbed in the proximal tubule and collecting ducts (see Figure 7b ). The rate of reabsorption is facilitated when urine flow down the tubule is low, and vice versa. This explains the rise of blood urea in oliguric states. Urea may be actively secreted into the urine by the pars recta of the proximal tubule, but the quantitative significance of this is uncertain. There is a high concentration of urea in the medullary interstitium, and this plays an important osmotic role in the concentration of urine by the countercurrent process, Organic anions, of which para-amino hippurate is the experimental prototype, are extensively but reversibly protein-bound, and therefore poorly filtered at the glomerulus. Free organic anions are actively secreted mainly into the S2 portion of the proximal tubule, and this promotes further unbinding from protein ( Figure 7c ). Examples include not only a range of endogenous substances, but many drugs including penicillins, cephalosporins, diuretics, and salicylates. Passive reabsorption of these substances may occur in the distal nephron, when there is an appropriate pH, as discussed above.
The excretion of organic cations is less well understood. Again, some are protein bound and therefore poorly filtered, but the major transport mechanism appears to be active secretion in the proximal tubules. Substances in this category include catecholamines, atropine, morphine, and cimetidine.
The main system of sodium reabsorption is the Na-K-ATP'ase pump of the proximal tubule ( Figure 7b ). Sodium is pumped out of the tubule cells into the paracellular spaces and interstitium in exchange for potassium. This pump system, together with the high permeability for sodium of the luminal cell membrane of the proximal tubular cell, favours net reabsorption. Passive osmotic movement of water with sodium serves to offset the tendency toward back-diffusion. In the early part of the proximal tubule, symport mechanisms provide for simultaneous reabsorption of glucose and amino acids with sodium.
Most chloride reabsorption is passive in association with the active transport of sodium. It is now recognised that active transport mechanisms also exist for chloride and a NaCl symport has been suggested.
Bicarbonate is effectively reabsorbed in the proximal tubule by means of the carbonic anhydrase system which secretes hydrogen ions into tubular fluid, with the formation of C02 and water from the bicarbonate therein, while new bicarbonate, together with sodium, is secreted into the renal cortical interstitium.
The net result of all the above processes is that 60-70070 of the glomerular filtrate is reabsorbed in the proximal tubule, with only minor changes in composition, largely due to concurrent passive reabsorption of water.
Function of the Loop of Henle and
Distal System The loop of Henle and the vasa recta function under the now well-known countercurrent principle. This process is most efficient in the juxtamedullary nephrons and its function is first to reabsorb a further 15-20% of solute and water from the nephron, but much more importantly, to set up a major osmotic gradient in the renal medulla so that further reabsorption of water can take place in the collecting duct. The descending limb of the loop of Henle possesses no known active transport mechanisms. However, because there is a gradient in sodium, chloride and urea as the loop descends further into the medulla, there is progressive flow of water out of the loop into the surrounding interstitium, and eventually into the vasa recta ( Figure 8 ). Both the ascending segment of the thin limb and the thick segment are responsible for the creation of this medullary osmotic gradient. The nature of the responsible transport mechanism is uncertain. Initially it was believed that an active reabsorption mechanism for sodium was involved. There is some evidence, however, to suggest that active chloride reabsorption also takes place, and recent experimental data strongly support the existence of an ATP'asedependent sodium-chloride symport.
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A countercurrent mechanism also exists in the renal medulla for urea, resulting in a very high urea concentration in the inner medulla. This urea concentration gradient occurs because water reabsorption takes place more rapidly than urea reabsorption in the ascending limb and distal tubule, resulting in progressive concentration of urea in the tubules, and a gradient of urea concentration favouring its reabsorption into the medullary interstitium from the collecting ducts. Medullary interstitial urea thus contributes significantly to the countercurrent mechanism and to the osmotic reabsorption of water in the loop of Henle and the collecting duct.
The distal tubule functions as an extension of the thick ascending limb. Active salt transport continues with control mediated by aldosterone, and, as permeability to water is low, there is progressive dilution of tubular fluid to 80-100 mosm/kg. The distal portion of the tubule is sensitive to ADH, which raises its water permeability, resulting in a further 5-8% passive reabsorption of water in this region.
The collecting duct is poorly permeable to electrolytes and water, and further active transport mechanisms exist for the removal of salts. However, in the presence of ADH, the duct can become freely permeable to water, and thus the composition of the residual 10070 (20 litres) of the glomerular filtrate can be adjusted to yield urine of volume and composition appropriate to the maintenance of the milieu interieur.
The urine concentrating mechanism thus depends upon active transport mechanisms in the ascending limb of the loop of Henle, the countercurrent arrangement of tubules and blood vessels, and the low inner medullary blood flow (50 ml/100 g/min). This permits an increase in osmolality in the medullary interstitIUm from 300 mosm/kg at the corti co medullary junction to 1200 mosm/kg at the inner medulla. Equilibration of collecting duct fluid with this high osmolality depends upon the action of ADH ( Figure 8 ). 
SUMMARY OF CHANGES IN TUBULE FLUID ALONG LENGTH OF NEPHRON
It is helpful to compare the concentrations of various substances in the tubule fluid with those in plasma, along the length of the nephron ( Figure 9 , Figure 5 ). For example fluid in the proximal tubule is iso-osmotic with plasma, becomes hyperosmotic at the medullary tip of the loop of Henle, is hypo-osmotic as it reaches the distal tubule and then may become hyperosmotic in the collecting duct under the influence of ADH. Another way of viewing these changes is to consider the fraction of the filtered substances remaining in the tubule fluid as it passes down the nephron (Figure 10 ). 
RENAL EFFECTS OF ANAESTHESIA
The observed major effects of anaesthesia and surgery on renal function and body fluid homeostasis have been assumed to be due to indirect circulatory and neuroendocrine responses. However, recent studies have demonstrated that anaesthetic agents also have direct effects on renal function which may be acute, or delayed, as exemplified by the delayed toxicity which has been reported after methoxyflurane anaesthesia. This section will discuss the combined effects of anaesthesia and surgery upon renal function and fluid- electrolyte homeostasis in normal man, anaesthetic problems of patients with renal disease having been described in other reviews,7.12 and in this symposium. Mention will also be made of renal effects of drug interactions which may occur between anaesthetics and therapeutic agents such as antibiotics and enzyme-inducing drugs.
ACUTE EFFECTS OF ANAESTHETICS ON RENAL FuNCTION
The earliest reports of the effects of anaesthesia on renal function were from Pringle et al. I3 in 1905. They reported the effects of ether anaesthesia on water and nonprotein nitrogen excretion in eight patients undergoing a variety of minor and major surgical procedures. Urine flow averaged 50 mllhour on the day prior to surgery, fell to 1.2 mllhour during the operation, and returned toward normal postoperatively.
In surgical patients without renal disease, all general anaesthetic agents temporarily depress renal function with urine flow, glomerular filtration rate (GFR), renal blood flow (RBF), and electrolyte excretion being reduced. This consistent and generalised depression of renal function has been attributed to many factors, including the type and duration of surgical procedure, the physical status of the patient, especially that of the cardiovascular and renal systems, pre-operative and intra-operative blood volume, fluid and electrolyte balance, the choice of anaesthetic agent and the depth of anaesthesia. 14 . 24 Changes in renal function following spinal and epidural anaesthesia have been reported to parallel the degree of sympathetic blockade and therefore the amount of hypotension produced. 25 . 26 In most cases the changes in renal function associated with anaesthesia and surgery revert spontaneously. At the termination of short uncomplicated procedures RBF and GFR usually return to normal within a few hours. When surgery is more extensive and anaesthesia prolonged, secondary effects related to the endocrine system may be manifested by impairment of the ability to promptly excrete a waterload,14 or conversely, inability to produce a concentrated urine. 27 . 28 The depression in renal function caused by anaesthetic agents may be due to their direct or indirect effects.
Indirect Circulatory Effects
During general anaesthesia RBF may be depressed as a consequence of renal vasoconstriction, systemic hypotension, or both. Drugs causing the greatest increase in catecholamine excretion, such as cyclopropane and diethyl ether,29 tend to support systemic blood pressure, but in so doing cause a marked increase in renal vascular resistance,decrease in RBF and depression of renal function. 20 This catecholamine effect may be accentuated in the presence of hypovolaemia. 3o Halothane and thiopentone, although not causing a catecholamine response, are associated with a moderate increase in renal vascular resistance 21 as blood is diverted from the kidney to compensate for hypotension induced by myocardial depression and peripheral vasodilation. Renal blood flow and GFR fall with these agents, but not as much as with anaesthetic agents that stimulate catecholamine release.
Some evidence suggests that circulating catecholamines may cause a redistribution of renal blood flow with a marked reduction occurring in cortical perfusion. 31 Redistribution is prevented by alpha-adrenergic blockade, but not by denervation of the kidney or by prophylactic administration of mannitol. Thus it is possible that administration of anaesthetic drugs with alpha-adrenergic blocking activity, such as droperidol, may result in the smallest changes in renal haemodynamics. 32 The mean blood pressure at which an injurious reduction of RBF occurs has not been precisely determined in man. Studies in dogs show a reduction in RBF with changes in distribution of cortical blood flow at a mean arterial blood pressure of 70 mmHg,33,34 during haemorrhagic shock. In this situation of increased sympathetic tone there is systemic vasoconstriction which includes the kidney. This may be associated with very low RBF at blood pressures which would usually be in the autoregulatory range for RBF (see Figure 6 ). Unfortunately, conclusive information is not available concerning renal blood flow and distribution of flow during vasodilatory hypotension in man such as is produced by ganglion blocking drugs 23 ,3S,36 ( Figure 6 ).
Indirect Sympathetic Nervous System
Effects As noted above, under a wide variety of normal and abnormal physiologic conditions, RBF is regulated to maintain stability of GFR. 37 With increasing stress, RBF decreases significantly, however filtration fraction (GFR/RBF) increases, GFR thereby remaining constant, suggesting efferent renal arteriolar constriction. Finally, during severe stress, GFR also decreases. Judged by their depressant effect on RBF and GFR, general anaesthesia, syncope, pain, severe exercise and haemorrhage represent severe stress. It has been assumed that the major renal effects of these diverse stimuli are mediated via sympathetic nervous system stimulation. Some evidence indicates that general anaesthesia may have important direct effects (see below).
Evidence for the role of the sympathetic nervous system in the renal effects of anaesthetics was provided by Berne's classic experiments in dogs with one normal and one denervated kidney.38 Prior to induction of pentobarbitone or chloralose anaesthesia, RBF and GFR of the denervated and normally innervated kidneys were the same. However, following induction of anaesthesia, RBF and GFR on the normally innervated side decreased while no changes were seen on the denervated 
Indirect Endocrine Effects
Endocrine effects on renal function during anaesthesia are closely tied to the circulatory effects discussed above. Most important in regulating urine volume is antidiuretic hormone (ADH). Renin, angiotensin, aldosterone, adrenaline, and noradrenaline also play important roles in electrolyte excretion and regulation of renal blood flow.
(a) Abnormalities in ADH Secretion
Although there are some conflicting data,44,45 the weight of evidence now indicates that opioid drugs and general anaesthetic agents are responsible for increased release of ADH. 4 ,46 As discussed above, this results in increased reabsorption of water from the collecting ducts and the elaboration of a concentrated urine. The combination of this effect with the decreased GFR associated with the use of inhalational general anaesthetics is a major potential cause of the concentrated urine and water retention which may follow general anaesthesia. 4 Preoperative depletion of extracellular fluid is a potent stimulus to ADH release and this may be reduced by administration of crystalloid solutions preoperatively. 47 However, neurogenic stimuli due to anxiety or pain and drug-induced stimulation of ADH release are unlikely to be affected. Also, haemodynamic changes resulting from blood loss and intermittent positive pressure ventilation may trigger ADH release via baroreceptors (Figure 12 ).
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( Both adrenaline and noradrenaline produce marked renal vasoconstriction, especially of afferent arterioles, with a decrease in RBF and, to a lesser degree, GFR. 51 Sodium, chloride and potassium excretion are depressed, probably due to the decreased filtered load or to increased reabsorption from the tubules. Antidiuresis may occur following administration of adrenaline and noradrenaline, and Eranko et al. 52 have suggested that ADH may be responsible. It is difficult to determine how much of the renal effect of anaesthetic agents such as ether and cyclopropane is due to the increase in catecholamines which they provoke and how much to their other systemic effects. (c) Renin-Angiotensin An additional hormonal pathway capable of affecting renal function is the reninangiotensin system. Control of renin release is complex and is influenced by several factors which are in turn affected by the administration 0 f anaesthesia. Sodium content of tubular fluid in the macula dens a region, catecholamine levels, sympathetic nervous impulses, and intraluminal pressure of afferent arterioles are probably all involved. 4 ,53,54 Deutsch et al. 55 have reported increased renin activity in two non-operated subjects anaesthetised with cyclopropane and two with halothane, In contrast, three of four subjects anaesthetised with morphine, thiopentone, nitrous oxide and muscle relaxants showed a decrease in renin activity. The authors suggest that a fall in renin activity might explain the relatively greater reduction in GFR than in RBF observed with this technique in comparison with cyclopropane or halothane. However, the number of patients is too small and the data too fragmentary for firm conclusions to be drawn. In patients undergoing cardiac surgery, under nitrous oxide and high-dose morphine anaesthesia, renin levels in peripheral venous blood increase with surgical stimulation but not with drug administration. lo Other events during anaesthesia and surgery may alter renin release and thus it is difficult to attribute altered renin levels to anaesthesia per se. Such events include sodium loading or depletion, altered sympathetic tone and renal per fusion, changes in RBF and distribution of RBF.
(d) Aldosterone
Aldosterone, the hormone responsible for moment to moment control of sodium excretion, is formed in the zona glomerulosa of the adrenal cortex. Its release is primarily dependent upon the juxtaglomerular apparatus (Figure 12 ), as discussed elsewhere in this review. It has been suggested that anaesthetics alter the response of atrial and other baroreceptors to changing blood pressures. 57 ,58 However, detailed studies of the effects of anaesthetics on sodium metabolism 59 are not available.
Despite anaesthesia-induced aldosterone release and the sodium retention it produces, it is well known that serum sodium concentration falls following general anaesthesia and surgery. This dilutional hyponatraemia has been ascribed to dominance of ADH effect, liberation of endogenous sodium-free water from oxidation of fat, and over-administration of sodium-free fluids. Indeed, the postoperative patient has in the past been thought to be intolerant of sodium administration and the practice of infusing small volumes of sodium-free fluid developed. 60 The recent reversal of this view is discussed below. considered above. In the isolated toad bladder, cyclopropane and nitrous oxide gave rise to dose-dependent stimulation, and halothane to dose-dependent inhibition, of active sodium transport. Ether produced a biphasic response with initial stimulation being followed by inhibition of ion transport. 61 These studies
Direct Effects of Anaesthetics on Renal
Function Direct effects of anaesthetic agents on renal function are obscured by the marked indirect haemodynamic and endocrine effects suggest that such effects could occur in the renal tubule.
In an effort to elucidate the mechanism of the above responses, Andersen performed additional experiments in bladders from toads previously treated with reserpine, alpha-or beta-adrenergic blocking agents and with adrenaline. Cyclopropane was used as the test gas. In untreated bladders, cyclopropane produced a dose-dependent stimulation of sodium transport, while in reserpinised bladders and those treated with alpha blockers, cyclopropane produced dose-dependent inhibition of sodium transport. Beta blockers had no effect upon the bladder response to cyclopropane. Andersen suggested that the inhibition of sodium transport by anaesthetic agents may be a direct effect whereas anaesthetic-induced catecholamine release caused a stimulation of sodium transport mediated via alpha receptors. Confirming his earlier studies, Andersen then showed that methoxyflurane, a non-catecholamine releasing agent, caused dose-related depression of sodium transport in untreated bladders. This effect gradually reversed after discontinuation of the anaesthetic. 63 Studies in goldfish tubules reported depressed organic acid transport with some anaesthetics. 64 In rabbit kidney slices Bastron et al. 43 reported dose-related depression of para-amino hippuric acid (PAH) accumulation with methoxyflurane, halothane, enflurane, fluroxene and diethyl ether. 4 ,43 Other in vitro studies showed that P AH uptake in suspensions of proximal tubules was decreased at 1 MAC levels of halothane and methoxyflurane. 4 If indeed anaesthetics alter P AH extraction by the kidney, these results cast considerable doubt on the validity of studies using P AH clearance as a measurement of RBF, in the absence of knowledge of renal vein PAH concentration. These concerns are borne out by recent studies where direct measurements of blood flow through, oxygen consumption by, and drug extraction across kidneys were made in a sheep model with chronically implanted vascular catheters. 39 Anaesthesia with 2 MAC halothane/400J0 oxygen/nitrogen balance and normocarbia resulted in decreases in renal blood flow to 50% of awake control values, with significant reductions in renal vein oxygen tensions. Intrinsic renal clearance (clearance corrected for changes in RBF) of a perfusion limited drug cleared by the kidney (cefoxitin) was markedly reduced (Table 1) . These changes persisted for some hours after anaesthesia. In comparison, spinal anaesthesia caused only very minor changes (Table 1) . Iodohippurate (IOH), handled in a similar manner to PAH by the kidney, showed considerable variation in extraction ratio from day to day, within animals and between animals. 39 It now seems clear that P AH extraction cannot be assumed to be constant in 'control'· measurements or under anaesthesia. The finding of marked reductions in intrinsic clearance of marker drugs is clear evidence of a direct effect of anaesthetics on tubular function.
SUMMARY OF ACUTE RENAL EFFECTS OF ANAESTHETICS
In many of the above studies it is impossible to dissect out the role of anaesthesia per se from other factors such as anxiety, pain, surgical stimulus or blood loss. Thus comparison of the many studies in patients during surgery shows wide variation in reported renal effects. 28 In healthy volunteers pretreated with 4% fructose/water, receiving 1.5 % halothane, Deutsch et al. reported that a 19% reduction in GFR and a 38% reduction in RBF occurred. 19 In patients prior to surgery, Cousins and Mazze reported similar changes in GFR and RBF at 1 MAC halothane, isoflurane and enflurane 65 ,66 ( Table 2 ). Renal effects of anaesthesia do appear to be dose-related and are favourably influenced by adequate repletion of extracellular fluid. Spinal anaesthesia has only minimal effects on RBF, GFR and oxygen consumption and does not influence the intrinsic clearance of marker drugs (Table 1) . It is not known whether the effects of anaesthesia are greater in diseased kidneys, although from first principles this would seem likely. Current opinion favours reduction of inner cortical blood flow as the initiating factor in acute tubular necrosis; the influence of anaesthetics on these changes is unknown. Finally it is now reported that hypoxia per se is capable of reducing renal cortical blood flow. In the surgical patient under anaesthesia complex factors may operate such as combined blood loss and hypoxia. Only direct measurements of GFR, RBF and oxygen consumption by the kidney can resolve these complex issues and point to the optimal management of patients at risk from a renal viewpoint. In the absence of sophisticated measurements, the clinician is well served by monitoring of hourly urine flow rate and measurement of urine sodium concentration at appropriate intervals.
DELAYED RENAL EFFECTS OF ANAESTHETICS:
DIRECT NEPHROTOXICITY
The kidney is particularly susceptible to damage from drugs or toxins because of its rich blood supply and increased concentration of compounds in renal tubular cells during reabsorption or secretion. Because of the countercurrent mechanism, medullary concentration of specific compounds is possible to a degree not found in the interstitial fluids of other tissues of the body. The amount of damage produced by nephrotoxins depends upon many factors such as the duration and intensity of exposure, the degree of toxin binding to plasma protein and tissues other than kidney, the degree and duration of binding to renal tissue, and the rapidity of renal or extra-renal elimination. Toxic damage to the kidney may be either acute or chronic, may predominantly affect glomerular or tubular function, or cause generalised renal damage. Toxicity can be manifested by anuria, oliguria or polyuria. An extensive review of the subject of toxic nephropathy has been written by Schreiner.
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ANAESTHETIC METABOLISM AND RENAL TOXICITY
Until the early 1960s, volatile anaesthetics were believed to be inert compounds not metabolised in the mammalian body. In 1964, using isotopically-Iabelled anaesthetics, it was shown that rats metabolise diethyl ether, chloroform and methoxyflurane to carbon dioxide, and halothane and methoxyflurane to chloride ion.
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Interest in the metabolism of volatile anaesthetics was greatly stimulated by the finding that renal dysfunction after methoxyflurane anaesthesia is caused by a metabolite of this agent.
.
70 Simultaneously, a toxic metabolite was implicated in the hepatic necrosis caused by fluroxene and by chloroform in laboratory animals.
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The impact of studies such as these can be seen from the current trend toward the use and development of anaesthetics which undergo minimal metabolism. 73 Clinical experience so far supports the enhanced safety of these agents with regard to organ toxicity.
The following brief discussion will be limited to four clinically important volatile anaesthetics -methoxyflurane, enflurane, isoflurane and halothane. Although use of methoxyflurane has diminished in the last decade, it is included here because studies relating its metabolism to nephrotoxicity brought about a change in attitude of anaesthetists towards anaesthetic toxicity ( Figure 13 ). Furthermore, because the Elfeels of anaeslhesia on renal funelion. nephrotoxic fluoride ion is formed (in lesser amounts) during metabolism of other volatile anaesthetics, the problem of renal toxicity is not exclusive to methoxyflurane. A more detailed review of the renal toxicity of inhalational anaesthetics has been given. 28 
METHOXYFLURANE
In humans, over 50070 of net absorbed methoxyflurane is metabolised, mostly with the formation of fluoride, dichloroacetic acid and methoxydifluoroacetic acid. Postoperative urinary oxalate excretion represents only about 7070 of absorbed methoxyflurane.
74
, 75 In 1966 sixteen cases of postoperative renal dysfunction, characterised by diuresis and poor response to a vasopressin challenge, were reported in a group of 94 patients who had received methoxyflurane. 76 Despite the high incidence of toxic effects observed in this study, 79 reported the results of a randomised, prospective study which left no doubt as to the nephrotoxicity of this anaesthetic.
A report in 1970 80 described a case of methoxyflurane nephrotoxicity associated with high levels of fluoride in serum and urine. Subsequently, peak serum levels of both fluoride and oxalate were found to correlate with renal dysfunction in patients receiving methoxyflurane. 69 It was pointed out that the observed symptoms were unlikely to be caused by oxalic acid, but indirect evidence indicated that fluoride could be responsible for the polyuric renal insufficiency. The observation of calcium oxalate deposition in the kidneys of patients suffering renal failure after methoxyflurane anaesthesia,8l,82 suggested the possibility that this was a contributing factor to the renal lesion. Cousins et al. 70 subsequently reported that fluoride is primarily responsible for methoxyflurane nephrotoxicity in an animal model. In Fischer 344 rats, administration of fluoride, in an amount sufficient to simulate the urinary fluoride excretion following a nephrotoxic dose of methoxyflurane, produced polyuric renal failure and morphological changes similar to those seen after methoxyflurane. On the basis of the same dose of methoxyflurane, injection of a stoichiometric equivalent quantity of oxalic acid produced no abnormalities. Ten times this dose of oxalic acid resulted in anuric renal failure and morphological changes unlike those due to methoxyflurane 70 (Figures 14, 15) . Thus, it appears that oxalic acid does not play a major role in the polyuric renal failure caused by methoxyflurane. It is, however, possible that calcium oxalate deposition may contribute to the lesion, especially in the case of the less common post-methoxyflurane chronic renal failure. 83 ,84 Hollenberg et al.,83 for example, described three cases of irreversible acute oliguric renal failure after methoxyflurane in which oxalate deposition was prominent. A case of generalised oxalosis after methoxyflurane has also been reported. 84 The patient had preexisting renal insufficiency, and phenobarbitone had been administered preoperatively. Methoxyflurane-nitrous oxide was administered for about three hours. At autopsy, calcium oxalate crystals were found in the kidney, thyroid, bronchus, heart and retina. Increased metabolism and renal insufficiency may have led to high plasma oxalate levels in this patient.
Clinical Features of Methoxyflurane Nephrotoxicity
In a randomised, prospective clinical study, Cousins and Mazze 85 reported details of changes in renal function at increasing doses of methoxyflurane (MOF) (Figures 16, 17) . Subclinical toxicity occurred after 2.5-3 MAC hours of MOF (serum F -> 50 micromoles/litre). This was manifested by delayed return to maximum preoperative urine osmolality, unresponsiveness to vasopressin (AD H) administration and elevated serum uric acid concentration. Mild clinical toxicity occurred after 5 MAC hours of MOF (Serum F-> 90 micromoles/litre). In addition to the abnormalities noted above, there was hypernatraemia, serum hyp.erosmolality, polyuria, and low urine osmolality. The latter two abnormalities were evidence of a waterlosing nephropathY and this was confirmed by the failure to respond to ADH (Figure 17 ). Urine osmolality also failed to respond to a water load, confirming the presence of both a diluting and a concentrating defect in renal tubules. This would result in inability to compensate for fluid restriction or a fluid overload. Frank clinical toxicity was present at 7 MAC hours MOF (Serum F-80 to 175 micromoles/litre). Abnormalities in serum and urine variables were more pronounced than at lower MOF doses and thirst and polyuria added difficulty to postoperative management.
Predisposing Factors in Methoxyflurane Nephrotoxicity
(a) Dose A dose-response relationship exists for methoxyflurane nephrotoxicity in man 85 and an animal mode1. 86 Parameters indicative of renal dysfunction correlate with dose of methoxyflurane (MAC-hours). Although nephrotoxicity was observed at peak serum fluoride levels above 50 micromoles per litre, it should be borne in mind that this peak level is only an indicator of total kidney exposure (concentration x time) to fluoride. More prolonged exposure of the kidney to concentrations as low as 25 micromoles/litre may result in nephrotoxicity.
(b) Genetic Factors Although Figure 15 indicates a strong doseresponse relationship, considerable individual variation is apparent in both peak serum fluoride concentration after a given dose of methoxyflurane and degree of nephrotoxicity observed at each fluoride level. This indicates individual variation in both extent of methoxyflurane metabolism and renal sensitivity to fluoride, presumably due in part to genetic factors. Animal experiments provide evidence of genetic differences in both metabolism and organ sensitivity. Of six inbred rat strains, only Fischer 344 rats developed renal toxicity after anaesthesia for 3 hours with 0.5070 methoxyflurane. 87 The susceptibility of this strain was due to both a high rate of methoxyflurane biotransformation and a high renal sensitivity to fluoride. Peak serum fluoride levels in paediatric patients (mean age 10.2 years) were found to be lower than those reported in adults after similar exposure to methoxyflurane. 88 This could be due to lower rates of methoxyflurane biotransformation or to altered fluoride pharmacokinetics (e.g. increased deposition in bone). No cases of methoxyflurane nephrotoxicity have been reported in children. ( 
d) Enzyme induction
Factors which increase methoxyflurane metabolism increase the risk of nephrotoxicity. Treatment of rats with the mixed-function oxidase inducer phenobarbitone increases methoxyflurane metabolism 70 ,89 and exacerbates nephrotoxici ty 90 ( Figure 18 ). Treatment with 3-methylcholanthrene, an inducer of cytochrome P-448, does not result in increased microsomal metabolism of this anaesthetic.
90 Administration of isoniazid, or other compounds contammg the hydrazine moiety, to rats results in increased rates of microsomal metabolism of methoxyflurane and other halogenated ether anaesthetics to inorganic fluoride. 91 ,92 Although the hepatic microsomal content of total cytochrome P-450 is not increased, a specific form of the cytochrome may be induced. 91 Presumably, mixed-function oxidase induction with appropriate agents increases methoxyflurane metabolism in man, but only indirect evidence is available to support this hypothesis. In the case of generalised oxalosis 
Pre-op greater renal impairment than does treatment with either drug alone. 93 These two drugs also exert a synergistic effect on the kidney in humans. Severity of methoxyflurane nephrotoxicity was apparently aggravated as a result of commencement of gentamicin therapy in the postoperative period 94 ( Figure 19 ). Tetracycline, a potentially nephrotoxic drug, has also been implicated as an exacerbating factor in methoxyflurane renal failure. 95 ,96 (f) Obesity
Young et al. 97 reported that obese patients develop higher serum fluoride levels during, and two hours after, methoxyflurane anaesthesia than do non-obese patients. Although it might be postulated that fat may serve as a depot for methoxyflurane, resulting in prolonged metabolism and sustained fluoride levels, in this study obese patients did not have higher serum fluoride levels in the three days following anaesthesia. However, Young et Due to its minimal metabolism and rapid excretion via the lungs, serum fluoride levels after enflurane are lower than those observed after methoxyflurane anaesthesia. After 2. The effect of prolonged enflurane anaesthesia on renal function has been studied in rats and man. In Fischer 344 rats, 6-10 hours of 2.5% enflurane resulted in renal dysfunction similar to that in another group receiving 1.5 hours of 0.25070 methoxyflurane. 102 Peak serum fluoride levels were similar in the two groups.
Renal effects of enflurane in man are dosedependent. In patients receiving a mean of 2.7 MAC-hours of enflurane, renal function was not impaired hours postoperatively. 65 Blood chemistry of volunteers receiving 9.6 MAC-hours of enflurane indicated minimal changes in renal function at 24 hours and 5 days.103 However, in a similar study in which renal function was assessed by maximum urine ?smolality in response to vasopressin, Impairment was observed 24 hours but not 5 days after anaesthesia.
(b) Enflurane and Other Neph:'otoxic Drugs
As is the case with methoxyflurane, administration of the nephrotoxin gentamicin to rats can exacerbate the renal effects of enflurane. Fischer 344 rats receiving gentamicin, 25 mg/kg twice daily for nine days, followed by 1 MAC enflurane for 6 hours, exhibited more pronounced morphological changes in the kidney and greater urine volumes than did animals receiving either gentamicin or enflurane alone. l05 With lower doses of gentamicin (5 mg/kg/day for 15 days) and enflurane (2% for 2 hours), no synergistic effect was observed in rats with surgically induced renal insufficiency.l06 Rats with surgically induced kidney damage, but not receiving gentamicin, developed only mild and reversible changes in renal function after 6 hours of 2% enflurane (20 Iml ar y, III a group of 102 s~rgical patie~ts classified according to drug hIstory, no dIfferences were found in peak serum fluoride concentration after enflurane between control patients and those taking miscellaneous drugs, ethanol or drugs known to cause enzyme induction (phenobarbitone phenytoin). 114 ' As mentioned earlier, the rate of metabolism of halogenated ether anaesthetics is increased in hepatic microsomes prepared from isoniazidtreated rats. 91 This effect is also observed in vivo. Isoniazid-treated Fischer 344 rats exposed to 2% enflurane became polyuric and excreted increased fluoride relative to similarly exposed rats not treated with isoniazid. ll5 Isoniazid has a similar effect in man. Almost half of 20 patients taking isoniazid prior to enflurane anaesthesia had unusually high peak serum fluoride concentrations following anaesthesia (over 100 micromoles/litre in three patients).ll6 It was suggested that susceptibility to this effect of isoniazid may be related to acetylator phenotype. As the hydrazine moiety is responsible for the inducing effect,92 enflurane should be used with caution in patients taking drugs containing this group. Alcohol has also been shown to enhance enflurane metabolism in rats,117,118 but the clinical significance of this finding has not been investigated. (d) Obesity
Obesity also contributes to elevated fluoride levels after anaesthesia. Cousins et al. 65 reported an obese patient who had a peak serum fluoride concentration of 52 micromoles/litre after 4 MAC-hours of enflurane. After similar exposures to enflurane, serum fluoride concentrations were higher in obese than in non-obese patients (28 versus 17 micromoles/litre).119,120 The rate of increase of serum fluoride levels during and after 2 MAChours of enflurane in obese patients (5.5 micromoles/litre/hour) was twice that in a nonobese group (2.5 micromoles/litre/hour). These differences were apparently due to more rapid biotransformation of enflurane in the obese group.
Overall, there appears to be little risk of fluoride nephrotoxicity after moderate doses of enflurane in the absence of risk factors. Reports of enflurane nephrotoxicity are rare, despite the fact that risk factors (obesity, gentamicin therapy, prolonged anaesthesia) are presumably present in a large number of enflurane administrations. Enflurane is excreted more rapidly than methoxyflurane, and this results in fluoride levels peaking earlier and returning to baseline levels more quickly in comparison to methoxyflurane. 65 ,I02 Thus, for the same peak serum fluoride concentration, exposure of the kidney to fluoride is more prolonged after methoxyflurane than after enflurane ( Figure 20 ).
ISOFLURANE
Although synthesised soon after enflurane, clinical introduction of isoflurane was delayed until 1981. This was partly due to initial difficulty in purifying the drug but also to subsequently disproven studies reporting carcinogenicity. Isoflurane, an isomer of enflurane, is metabolised to inorganic fluoride and trifluoroacetic acid in both rats and man.122-124 As studies with enflurane have shown the difluoromethyl group to be metabolically stable, biotransformation of isoflurane is likely to proceed by initial attack at the chlorine-bearing carbon.
Isoflurane is metabolised to a lesser extent than other clinically used volatile anaesthetics. In humans, almost the entire dose is exhaled unchanged, less than 0.2070 is excreted as urinary metabolites. 123 Fischer 344 rats also metabolise isoflurane minimally, serum fluoride concentration reaching only 6.5 micromoles/litre after 4 MAC-hours and 7.3 micromoles/litre after 15 MAC-hours of isoflurane 121 (preanaesthetic values are 2-3 micromoles/litre).
Due to the minimal extent of metabolism of isoflurane, fluoride nephrotoxicity has not been associated with its use in man 66 or rats.
l21 In humans, peak serum fluoride concentrations average 4.4 micromoles/litre (twice the preanaesthetic value), well below the nephrotoxic threshold, after 1.2-5.3 MAChours of isoflurane 66 ( Figure 20) .
INFLUENCE OF ANAESTHETIC MANAGEMENT
ON THE INCIDENCE AND SEVERITY OF POSTOPERATIVE ACUTE RENAL FAILURE A number of aetiological factors, acting singly or in combination, must be considered when evaluating a patient who develops postoperative acute renal failure (ARF) ( Table 3 ). The factors most commonly encountered are those which act by reduction of RBF to produce renal ischaemia. These are the m.ost amenable to modification by sound anaesthetic practice. The predominantly vascular aetiology of this type of ARF 5 ,125 has led to the use of the term "vasomotor nephropathy". Reduction of RBF to 50-70% of normal results in sustained I.
n. Ill. IV.
V. This may prevent re-establishment of blood flow, even if the initial insult is effectively treated -the "no-reflow phenomenon".4 It seems likely that the renin-angiotensin system plays a powerful role in the production of renal cortical ischaemia via afferent arteriolar constriction. Improvement in RBF will often result in an increase in urine output, and prevent or ameliorate the development of ARF, but it by no means follows that any intervention which improves urine output will be ultimately beneficial to the oliguric patient. For example, administration of frusemide intravenously might maintain a normal or increased urine output, but hypovolaemia might be exacerbated, leading to a reduction in GFR and RBF.
VI.
There was previously controversy concerning the use of sodium-containing fluids in surgical patients.126-131 Most clinicians now agree that some salt-containing solution is beneficial in TABLE 4 "A t risk" situations for the kidney.
1.
Cardiopulmonary bypass 133 or surgery of the aorta l31 or renal vessels.
2.
Major biliary tree surgery. 134 3. Procedures in which large volume of blood may be trans fused. 135 4. Hypovolaemic hypotension. 136 5. Lengthy or extensive surgical procedures in older patients. l37 (ARF Mortality < 50070 at < 40 years, > 80070 above 80 years age.) 6. Surgery in patients with pre-existing renal disease. 138 7. Obstetric complications such as abruptio placentae. 139 8. Major trauma. 135.140 9. Transfusion of mismatched blood. 14o 10. Cardiac or hepatic failure. 4 11. Rhabdomyolysis and myoglobinuria 4 (e.g. Prolonged coma, malignant hyperthermia). 12. Septicaemia. 4 Anaesthesia and Inlensive Care, Vol. J J, No. 4 . major surgery, with the amount infused proportional to the degree of surgical trauma. 132 - 134 However, it is necessary to assess the response to intravenous fluids by measurement of urine volume and content, as well as by non-renal parameters such as left atrial pressure and auscultation of lung bases.
Whenever anaesthesia is proposed in a patient considered to have a high risk of developing postoperative ARF135-142 ( Table 4) the following strategies should be considered:
1. Bladder catheterisation and measurement of hourly urine volume is the only practical means of following renal function intraoperatively, and should be regarded as mandatory in any high-risk case. Mechanical patency of the urine drainage system should be checked whenever unexpected "oliguria" occurs. Periodic determination of urine sodium concentration may occasionally be helpful. 138.150 suggested that large doses of mannitol were effective in preventing renal failure in patients undergoing aortic aneurysm surgery, and cardiac valve replacement. It is possible that the main action of mannitol in these studies was as a volume expander. The current status of diuretics in protection from ARF is similar to that of steroids in shock -there is strong experimental evidence that diuretics significantly protect kidneys when given before an ischaemic insu1t151.152 but both clinical and experimental data relating to diuretics given after oliguria ensues are disappointing.151.153 It is often claimed that the administration of diuretics in high doses predisposes to the development of non-oliguric ARF, which has a better prognosis than the oliguric form. There appear to be few scientific data to either support or contradict this claim.
Maintenance of an
The administration of diuretics for the prevention of renal failure remains a widespread practice. It is important to remember that unrecognised hypovolaemia may be worsened by large doses of diuretics, and the question of toxicity, particularly ototoxicity and nephrotoxicity of frusemide, should be borne in mind.
6. Other approaches. Promising experimental data are available for a number of agents which may have a role in preventing the onset of ARF. These include adenosine triphosphate (ATP),154 magnesium chloride,154 beta-blocking drugs 156 and calcium antagonists. 156 The role of spinal and epidural blockade in patients "at risk" needs to be defined, however, favourable effects reported in normal kidneys25.26.39 indicate the need for further studies. 7. Persistent Oliguria. In those patients in whom oliguria persists it is important to distinguish pre-renal oliguria from established ARF. Table 5 lists those diagnostic features which are the most helpful in this regard. 
